Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 143.26
0.944 %
$ 14.5 B
Market Cap
38.2
P/E
NBIX - REVENUE
Revenue NBIX - Neurocrine Biosciences, Inc.
1.89 B
LAST VALUE
29.03%
2 YEAR CAGR
33.13%
5 YEAR CAGR
91.01%
10 YEAR CAGR